O
OrbiMed Portfolio holdings
AUM
$3.98B
This Quarter Return
+10.04%
1 Year Return
+13.05%
3 Year Return
+159.74%
5 Year Return
+207.27%
10 Year Return
+1,027.33%
AUM
$8.27B
AUM Growth
+$8.27B
(-0.65%)
Cap. Flow
-$508M
Cap. Flow
% of AUM
-6.15%
Top 10 Holdings %
Top 10 Hldgs %
34.32%
Holding
163
New
21
Increased
24
Reduced
50
Closed
15
Top Buys
| 1 |
Humana
HUM
|
$108M |
| 2 |
Cigna
CI
|
$87.3M |
| 3 |
PRNB
Principia Biopharma Inc. Common Stock
PRNB
|
$76.1M |
| 4 |
Molina Healthcare
MOH
|
$72.7M |
| 5 |
Sarepta Therapeutics
SRPT
|
$64.9M |
Top Sells
| 1 |
Alnylam Pharmaceuticals
ALNY
|
$125M |
| 2 |
Biogen
BIIB
|
$91M |
| 3 |
Merck
MRK
|
$80.6M |
| 4 |
Select Medical
SEM
|
$74.3M |
| 5 |
Boston Scientific
BSX
|
$65.9M |
Sector Composition
| 1 | Healthcare | 95.17% |
| 2 | Financials | 0.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Coherus Oncology, Inc. Common Stock
CHRS
$135M
| $28.4M | 0.34% | 1,722,400 +241,918 | +16% | +$3.99M |
|
77
Gilead Sciences
GILD
$140B
| $28.2M | 0.34% | 364,600 | – | – |
|
78
Cartesian Therapeutics
RNAC
$261M
| $26.3M | 0.32% | 1,692,797 -150,000 | -8% | -$2.33M |
|
79
Verrica Pharmaceuticals
VRCA
$52.8M
| $24M | 0.29% | 1,479,733 | – | – |
|
80
Stryker
SYK
$150B
| $23.1M | 0.28% | 130,200 -13,200 | -9% | -$2.35M |
|
81
CRISPR Therapeutics
CRSP
$4.71B
| $22M | 0.27% | 496,200 | – | – |
|
|
SVA
82
DELISTED
Sinovac Biotech, Ltd
SVA
| $21.6M | 0.26% | 2,839,500 | – | – |
|
|
NVTA
83
DELISTED
Invitae Corporation
NVTA
| $21.3M | 0.26% | 1,274,549 -243,648 | -16% | -$4.08M |
|
84
Amicus Therapeutics
FOLD
$2.34B
| $21.3M | 0.26% | 1,763,277 -5,309,223 | -75% | -$64.2M |
|
85
Intellia Therapeutics
NTLA
$1.22B
| $21.3M | 0.26% | 744,600 -131,400 | -15% | -$3.76M |
|
|
ALPN
86
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| $20.9M | 0.25% | 3,298,516 | – | – |
|
87
Spyre Therapeutics
SYRE
$996M
| $20.7M | 0.25% | 2,165,524 +300,000 | +16% | +$2.87M |
|
88
scPharmaceuticals
SCPH
$295M
| $20M | 0.24% | 3,409,865 | – | – |
|
|
AET
89
DELISTED
Aetna Inc
AET
| $19.9M | 0.24% | +98,200 | New | +$19.9M |
|
90
Rocket Pharmaceuticals
RCKT
$354M
| $19.1M | 0.23% | 775,000 | – | – |
|
|
91
Select Medical
SEM
$1.61B
| $19M | 0.23% | 1,034,711 -4,039,489 | -80% | -$74.3M |
|
92
Neurocrine Biosciences
NBIX
$13.8B
| $16.9M | 0.2% | 137,800 | – | – |
|
93
Natera
NTRA
$23.1B
| $16.4M | 0.2% | 684,086 -300,000 | -30% | -$7.18M |
|
|
WHWK
94
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$84.8M
| $16M | 0.19% | 5,193,946 | – | – |
|
|
VRNA
95
Verona Pharma
VRNA
$9.16B
| $15.6M | 0.19% | 1,250,396 | – | – |
|
96
Novo Nordisk
NVO
$251B
| $15.6M | 0.19% | 330,000 | – | – |
|
|
DBVT
97
DBV Technologies
DBVT
$264M
| $14.9M | 0.18% | 665,200 +254,500 | +62% | +$5.72M |
|
|
IMGN
98
DELISTED
Immunogen Inc
IMGN
| $13.9M | 0.17% | 1,469,189 -1,435,081 | -49% | -$13.6M |
|
|
PVLA
99
Palvella Therapeutics, Inc. Common Stock
PVLA
$599M
| $13.8M | 0.17% | 2,455,900 -684,100 | -22% | -$3.83M |
|
|
RDUS
100
DELISTED
Radius Health, Inc.
RDUS
| $13.6M | 0.16% | 762,900 | – | – |
|